NCT06697119View on ClinicalTrials.gov

Efficacy and Safety of Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome

NAActive, not recruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

March 9, 2023

Primary Completion Date

July 3, 2024

Study Completion Date

April 25, 2027

Conditions
Irritable Bowel Disease
Interventions
OTHER

Fecal Microbial Transplantation

Fecal suspension is delivered to duodenal 3rd portion via esophagogastroduodenoscopy

Trial Locations (1)

Unknown

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Hospital

OTHER